Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Geriatric assessment techniques in CLL

Lukas Smolej • 7 Oct 2022
ERIC 2022
Chronic Lymphocytic Leukemia Leukemia

Lukas Smolej, MD, PhD, Charles University, Hradec Králové, Czech Republic, discusses the challenges associated with performing a frailty assessment in patients with chronic lymphocytic leukemia (CLL), explaining that a comorbidity assessment might be more appropriate for this particular disease. Prof. Smolej further describes other geriatric assessments; however, these are not validated for CLL. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lukas Smolej

2:31
The role of chemoimmunotherapy in the era of targeted therapies for CLL
Lukas Smolej • 7 Oct 2022
1:25
Genomic testing and therapeutic decisions in routine clinical practice in CLL
Lukas Smolej • 7 Oct 2022
2:29
The efficacy & toxicity of venetoclax-based combination therapies in CLL
Lukas Smolej • 7 Oct 2022
1:03
Genomic tests available to patients with CLL at tertiary hospitals
Lukas Smolej • 7 Oct 2022

Related Videos

2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals